leisure time -WSS

leisure time

author：entertainment 2025-09-03 03:46:28 - browse：9444

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Scrutiny of post

leisure time

WSS

Investigation reveals sickle cell patients pressured into sterilizations

Biogen joins immunology wave with $1.15 billion acquisition of HI

Investigation reveals sickle cell patients pressured into sterilizations

iTeos Therapeutics debuts first data on TIGIT

Antibiotic resistance nearly killed me, so I'm raising awareness of it

At flashy new research hub, AstraZeneca lays out ambitious growth goals

explore

leisure time

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Biohaven protein

George Santos makes 1st court appearance after pleading not guilty to 13 counts

AI used to predict Covid

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Adam's Biotech Scorecard: Do Sarepta's exon

focus

Study finds gene variants tied to breast cancer risk in Black women

Study finds gene variants tied to breast cancer risk in Black women

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Digital health: a case of mistaken identity

Bird flu surveillance in wastewater gets boost from consortium

Latest bird flu infection made farmworker sicker than earlier cases

focus

leisure time

hotspot

leisure time